<DOC>
	<DOC>NCT01970800</DOC>
	<brief_summary>The purpose of the study is to evaluate the predictive value of IGF-1 generation test for growth velocity during GH treatment for 12 months.</brief_summary>
	<brief_title>The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>ability to provide written informed consent Prepubertal males and females form 5 11years old Bone age &lt;11 years in males and &lt;9 years in females Height SD score&lt;2.25SD in males and females IGF1SD score &lt;1SD in both males and females Peak GH level after stimulation &gt;10ng/ml History of prior chemotherapy and or radiation Active neoplasm Pediatric patients with closed epiphyses PraderWilli syndrome, Turner syndrome or any other genetic or chromosomal anomaly Treatment with inhaled or systemic steroids BMI &lt;5th percentile or &gt;95th percentile Tanner 2 at clinical or biochemical examination by ultrasensitive LH and FSH</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>IGF-1</keyword>
	<keyword>Short Stature</keyword>
	<keyword>GH</keyword>
</DOC>